Release date: 2026-07-08 11:17:28 Recommended: 14
Laos's pharmaceutical industry started late and remains relatively small in scale; for a long time, domestic drug supply has relied on imports from China, India, and other countries. In recent years, as Laos has increased its opening-up and introduced preferential policies, a number of pharmaceutical companies have chosen to establish factories here, and the sector has shown certain growth momentum. In 2026, Laos officially graduated from the Least Developed Country (LDC) status, and its drug registration standards have been upgraded from the WHO prequalification pathway to ICH standards, with GMP requirements raised simultaneously. The following is an overview of the main legitimate pharmaceutical manufacturers currently operating in Laos.
Lucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020 and is headquartered at No. 26, Thongmang Village, Xaythany District, Vientiane Capital, Laos. As a representative enterprise in Laos's generic drug sector, Lucius Pharmaceuticals originates from its parent company based in Hyderabad, India.
Production Scale: The factory covers an area of approximately 210,000 square meters and houses the Asia-Pacific No.1 Smart Factory, equipped with cutting-edge pharmaceutical machinery from China, the United States, Germany, and other countries, with an annual production capacity exceeding 1.5 billion tablets.
Product Portfolio: Currently produces over 200 generic drugs, covering multiple therapeutic areas including oncology, cardiovascular diseases, diabetes, hematology, dermatology, men's health, and anti-aging. As of June 2024, it has obtained marketing authorizations for 54 anti-cancer drugs, including generic versions of targeted therapies such as sotorasib, osimertinib, cabozantinib, and ivosidenib.
Certifications: Has obtained GMP certification from the Lao Ministry of Health, and its products are registered and approved by the Food and Drug Administration under the Lao Ministry of Health, granting legal production and sales qualifications. In October 2023, the World Health Organization conducted a comprehensive inspection of the Lucius Pharmaceuticals factory and confirmed that it fully complies with WHO standards.
Market Presence: Business has expanded to 12 countries including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Japan, and China.
ASEAN (Laos) Pharmaceutical and Food Co., Ltd. was established in 2012 and is the first pharmaceutical company in Laos to obtain GMP certification. The company currently holds more than 50 approved drug products, covering oncology, chronic diseases, infectious diseases, and other fields.
Element Pharma (Laos) Co., Ltd. was founded in 2019 and is located in the Boten Special Economic Zone, Laos. The company was established with the participation of the technical team from the Artificial Intelligence Bio-medical Technology Research Institute of Nanjing University in China, with a factory area of 2,500 square meters. Element Pharma focuses on the generic manufacturing, production, and sales of anti-tumor and men's health drugs, and has currently exported pharmaceutical products to more than 120 countries and regions across Asia, Africa, Europe, and Latin America.
Laos United Pharmaceutical Group was founded in 2017 as a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. It is currently the largest pharmaceutical company in Laos, accounting for approximately 27% of the domestic drug market share. The Second State Pharmaceutical Factory of Laos was established in the 1970s as a state-owned enterprise directly under the Lao Ministry of Health, producing over 160 types of drugs including infusions, injections, oral tablets, and capsules. Other players include Daewoong Pharmaceuticals, the Third Pharmaceutical Factory of Laos, and others.
Overall, the pharmaceutical industry in Laos is in a phase of rapid development. A number of legitimate manufacturers, represented by Lucius Pharmaceuticals, have formed large-scale production capabilities and have obtained official Lao GMP certifications and product registration numbers.
Laos's pharmaceutical industry started late and remains relatively small in ···【more】
Recommended:15Release date: 2026-07-08
Before 2020, there were only a handful of legally approved local pharmaceutical ···【more】
Recommended:29Release date: 2026-07-07
With generic drugs as its core, Laos' pharmaceutical industry has formed an ···【more】
Recommended:61Release date: 2026-07-02
The pharmaceutical industry in Laos started late and is limited in scale, with d···【more】
Recommended:240Release date: 2026-07-01
Lucius Pharmaceuticals (Lao) Co., Ltd is a Lao pharmaceutical company establishe···【more】
Recommended:92Release date: 2026-06-30
The Lao generic pharmaceutical industry has developed rapidly in recent years, a···【more】
Recommended:77Release date: 2026-06-29
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:754Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:715Release date: 2024-07-09
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagoli···【more】
Recommended:40Release date: 2026-07-06
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strict···【more】
Recommended:59Release date: 2026-07-03
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has f···【more】
Recommended:90Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durv···【more】
Recommended:194Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:539Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:488Release date: 2025-12-15